* BIO-Key International Inc BKYI.OQ BKYI.O is expected
to show
a rise in quarterly revenue when it reports results on March
31.
* The Wall New Jersey New Jersey-based company is expected
to
report a 86.1% increase in revenue to $1.74 million from
$934.93 thousand a year ago, according to the estimate from one
analyst, based on Refinitiv data.
* Refinitiv's mean analyst estimate for BIO-Key
International Inc
is for a loss of 27 cents per share.
* The one available analyst rating on the shares is "buy".
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for BIO-Key
International Inc is $2, above its last closing price
of $0.78.
This summary was machine generated March 29 at 12:37 GMT. All
figures in US dollars unless otherwise stated